Related Experiment Video
Updated: Mar 24, 2026
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future
Luis Sifuentes-Dominguez1, Ashish S Patel1
1Children's Health, UT Southwestern Medical Center, Dallas, Texas, USA.
Insights
Personalized medicine for ulcerative colitis (UC) is crucial due to disease variability. Genetic factors are key to predicting treatment response and guiding individualized therapeutic strategies for this chronic condition.
Area of Science:
- Gastroenterology and Genetics
- Inflammatory Bowel Disease Research
Background:
- Ulcerative colitis (UC) is a chronic, relapsing-remitting inflammatory bowel disease with significant patient variability.
- Increasing diagnosis in children presents lifelong challenges, with no current medical cure for UC.
- Predicting treatment response and surgical necessity at diagnosis remains a major clinical challenge.
Purpose of the Study:
- To explore individualized or personalized treatment strategies for UC.
- To discuss the role of genetic risk factors in UC pathogenesis and therapeutic outcomes.
- To review traditional and novel therapeutic agents for ulcerative colitis.
Main Methods:
- Review of existing literature on UC genetics and treatment.
- Analysis of phenotypic and genotypic variability in ulcerative colitis.
- Discussion of current and emerging therapeutic approaches.
Main Results:
- Genetic factors significantly influence UC variability and treatment response.
- Personalized treatment strategies hold promise for improving patient outcomes.
- Integrated approaches combining multiple scientific disciplines are essential for future UC management.
Conclusions:
- Individualized therapy based on genetic profiles is critical for effective UC management.
- Understanding genetic interactions is key to advancing UC pathogenesis and treatment.
- Future UC care will likely involve multidisciplinary, genetically informed strategies.
Abstract:
Ulcerative colitis (UC) is a relapsing and remitting disease with significant phenotypic and genotypic variability. Though more common in adults, UC is being increasingly diagnosed in childhood. The subsequent lifelong course of disease results in challenges for the patient and physician. Currently, there is no medical cure for UC. Even though surgical removal of the colon can be curative, complications including infertility in females make colectomy an option often considered only when the disease presents with life-threatening complications or when medical management fails. One of the greatest challenges the clinician faces in the care of patients with UC is the inability to predict at diagnosis which patient is going to respond to a specific therapy or will eventually require surgery. This therapeutic conundrum frames the discussion to follow, specifically the concept of individualized or personalized treatment strategies based on genetic risk factors. As we move to therapeutics, we will elucidate traditional approaches and discuss known and novel agents. As we look to the future, we can expect increasing integrated approaches using several scientific disciplines to inform how genetic interactions shape and mold the pathogenesis and therapeutics of UC.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:29Pharmacogenomics: Identification of New Drug Targets
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...